Aescap Venture
Aescap Venture is an Amsterdam-based investment company that pursues investments in biotech companies in Europe and the U.S.
Business Model:
Revenue: $0
Employees: 2-10
Rankings
Industries / Tags:
Detailed Aescap Venture Information
Geographic Data
Address: Spaces, Barbara Strozzilaan 101
City: Amsterdam
State: other
Zip: 1083 HN
Country: NL
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Aescap is a venture capital firm that focuses on investing in early stage biotechnology firms.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 6/2008 | Vivendy Therapeutics | Series B | 30.5M |
| 3/2010 | Affectis Pharmaceuticals | Series D | 4.5M |
| 2/2011 | to-BBB | Series B | 5.5M |
| 4/2010 | Biocartis | Series B | 40M |
| 7/2009 | EOS (Ethical Oncology Science) | Series A | 17M |
| 7/2007 | Aquapharm Biodiscovery | Series B | 8.2M |
| 10/2006 | Affectis Pharmaceuticals | Series C | 15.1M |
| 11/2020 | F-Star Therapeutics | Post-IPO Equity | 0 |
| 9/2007 | F-Star Therapeutics | Series A | 8.3M |
| 5/2007 | ProtAffin Biotechnologie | Series A | 0 |
| 4/2011 | F-Star Therapeutics | Venture Round | 0 |
| 2/2009 | ActoGeniX | Private Equity Round | 17.4M |
| 2/2007 | ActoGeniX | Venture Round | 26.1M |
| 4/2010 | Aquapharm Biodiscovery | Series C | 6.4M |
| 5/2014 | Avantium | Series G | 0 |
| 9/2011 | Orphazyme | Series A | 0 |
| 6/2011 | Avantium | Venture Round | 0 |
| 10/2008 | Avantium | Venture Round | 18M |
| 10/2013 | F-Star Therapeutics | Series A | 0 |
| 11/2010 | i-Optics | Series C | 5.8M |
| 1/2010 | F-Star Therapeutics | Series A | 11.5M |
| 1/2015 | Orphazyme | Series B | 0 |
| 11/2017 | Orphazyme | Post-IPO Equity | 0 |
| 7/2007 | to-BBB | Series A | 5.4M |
| 3/2017 | Orphazyme | Venture Round | 0 |
| 1/2008 | ProtAffin Biotechnologie | Series A | 0 |
| 5/2015 | i-Optics | Venture Round | 15.1M |
| 10/2009 | Biocartis | Series A | 14.9M |
| 11/2020 | F-Star Therapeutics | Post-IPO Equity | 0 |
| 11/2017 | Orphazyme | Post-IPO Equity | 0 |
| 3/2017 | Orphazyme | Venture Round | 0 |
| 5/2015 | i-Optics | Venture Round | 0 |
| 1/2015 | Orphazyme | Series B | 0 |
| 5/2014 | Avantium | Series G | 0 |
| 10/2013 | F-Star Therapeutics | Series A | 0 |
| 9/2011 | Orphazyme | Series A | 0 |
| 6/2011 | Avantium | Venture Round | 0 |
| 4/2011 | F-Star Therapeutics | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
